ASK REDCHAT ANYTHING ABOUT MOLECULIN BIOTECH INC.
Moleculin Biotech Inc. (NASDAQ: MBRX)
Listen to this Section
$2.56
+0.1000
(
+4.07% )
193.5K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Annamycin + Ara-C (Cytarabine)DetailsBlood cancer, Cancer, Acute myeloid leukemia |
Phase 3 |
| WP1066 (p-STAT3 inhibitor)DetailsSolid tumor/s, Brain tumor, Cancer, Glioblastoma |
Phase 2 |
| WP1122DetailsCOVID-19 |
Phase 2 |
| AnnamycinDetailsSoft tissue sarcoma, Solid tumor/s, Cancer, Lung Metastases, Sarcoma |
Phase 1/2 |
| WP1066 (p-STAT3 inhibitor)DetailsCancer, Brain tumor, Solid tumor/s, Glioma |
Phase 1/2 |
| WP1220DetailsCancer, T-cell lymphoma, Cutaneous T cell lymphoma, Blood cancer |
Phase 1 |
Market Data
|
| Open |
$2.56 |
| Previous Close |
$2.46 |
| Volume |
193.5K |
| Market Cap |
$13.13M |
| Day Range |
$2.40 - $2.63 |
| 52 Week Range |
$1.79 - $24.00 |
| Shares Outstanding |
5.34M |
| Change % |
+4.07% |
| Net Change |
▲ 0.1000 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2016 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
214,947.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-06-23 |
Buy |
3750.00 |
KLEMP WALTER V |
| 2025-06-23 |
Buy |
2711.00 |
Foster Jonathan P. |
| 2025-06-23 |
Buy |
2711.00 |
Foster Jonathan P. |
| 2024-07-05 |
Sale |
-982.00 |
KLEMP WALTER V |
| 2024-06-25 |
Sale |
-4329.00 |
Foster Jonathan P. |
| 2024-06-25 |
Sale |
-8990.00 |
KLEMP WALTER V |
| 2024-06-25 |
Sale |
-1766.00 |
PICKER DONALD H |
| 2024-06-21 |
Sale |
-2712.00 |
Foster Jonathan P. |
| 2024-06-21 |
Sale |
-1078.00 |
PICKER DONALD H |
| 2024-06-21 |
Sale |
-3750.00 |
KLEMP WALTER V |
SEC Filings
No data available for selected period.